FindTrial
Sign In

Filgrastim (G-CSF)

DRUG12 trials

Sponsors

M.D. Anderson Cancer Center, National Cancer Institute (NCI), National Heart, Lung, and Blood Institute (NHLBI), University of Miami, University of Illinois at Chicago

Conditions

Acute Lymphoblastic LeukemiaAcute Myelogenous LeukemiaBeta ThalassemiaBreast CancerChronic Lymphocytic LeukemiaChronic Myelogenous LeukemiaHHV-8HIV

Phase 1

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Chronic Lymphocytic Leukemia
CompletedNCT00002838
M.D. Anderson Cancer CenterLeukemia
Start: 1995-12-31End: 2002-07-31Updated: 2012-07-31
High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer
CompletedNCT00002837
M.D. Anderson Cancer CenterBreast Cancer
Start: 1995-09-30End: 2002-01-31Updated: 2012-07-31
TMI With HD Mel in ASCT for R/R Multiple Myeloma (BMT-03)
CompletedNCT02043847
University of Illinois at ChicagoMultiple Myeloma, Refractory to Standard Treatment, Multiple Myeloma, Relapsed
Start: 2014-01-14End: 2016-09-14Updated: 2024-11-13
Total Marrow Irradiation With High Dose Melphalan Prior to Autologous Transplant for Multiple Myeloma
TerminatedNCT02043860
University of Illinois at ChicagoMultiple Myeloma
Start: 2014-01-10End: 2016-11-07Updated: 2019-10-14
Epigenetic Reprogramming in Relapse/Refractory AML
CompletedNCT03263936
Therapeutic Advances in Childhood Leukemia ConsortiumAcute Myelogenous Leukemia
Start: 2017-07-11End: 2022-02-10Updated: 2025-10-16
Addition of JSP191 (C-kit Antibody) to Nonmyeloablative Hematopoietic Cell Transplantation for Sickle Cell Disease and Beta-Thalassemia
Active, not recruitingNCT05357482
National Heart, Lung, and Blood Institute (NHLBI)Beta Thalassemia, Sickle Cell Anemia
Start: 2022-05-12End: 2027-01-31Updated: 2026-03-12

Phase 2

Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity
Active, not recruitingNCT00092222
National Cancer Institute (NCI)HHV-8, HIV, Lymphoproliferative Disorder +1
Start: 2004-10-28End: 2026-10-01Updated: 2026-03-31
Methods to Enhance the Safety and Effectiveness of Stem Cell Transplants
CompletedNCT00378534
National Heart, Lung, and Blood Institute (NHLBI)Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Chronic Lymphocytic Leukemia +2
Start: 2006-09-30End: 2014-04-30Updated: 2021-06-16
Allogeneic Blood Stem Cell Transplantation and Adoptive Immunotherapy for Hodgkin's Disease
CompletedNCT00385788
M.D. Anderson Cancer CenterHodgkin's Disease
Start: 2005-07-31End: 2016-08-31Updated: 2018-05-09
R-MACLO-IVAM and Thalidomide in Untreated Mantle Cell Lymphoma
CompletedNCT00450801
University of MiamiLymphoma
Start: 2004-04-30End: 2015-07-31Updated: 2015-11-10

Phase 3

Combination Chemotherapy in Treating Patients With Lymphoma
CompletedNCT00002835
M.D. Anderson Cancer CenterLymphoma
Start: 1995-10-30End: 2004-02-04Updated: 2018-11-15
Filgrastim Plus Chemotherapy Compared With Filgrastim Alone In Treating Women Undergoing Peripheral Stem Cell Transplantation For Breast Cancer
CompletedNCT00002836
M.D. Anderson Cancer CenterBreast Cancer
Start: 1995-09-26End: 2006-03-09Updated: 2018-11-06

Related Papers

Inflammasome activation in patients with Kaposi sarcoma herpesvirus–associated diseases
Blood2024-06-2816 citations
Nivolumab Plus 5-Azacitidine in Pediatric Relapsed/Refractory Acute Myeloid Leukemia (AML): Phase I/II Trial Results from the Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) Consortium
Cancers2024-01-248 citations
A Phase I/II Open-Label Study of Molibresib for the Treatment of Relapsed/Refractory Hematologic Malignancies
Clinical Cancer Research2022-11-0930 citations
<scp>R‐MACLO‐IVAM</scp> regimen followed by maintenance therapy induces durable remissions in untreated mantle cell lymphoma ‐ Long term follow up results
American Journal of Hematology2021-03-184 citations
A phase 1 trial of autologous stem cell transplantation conditioned with melphalan 200 mg/m<sup>2</sup>and total marrow irradiation (TMI) in patients with relapsed/refractory multiple myeloma
Leukemia & lymphoma/Leukemia and lymphoma2017-10-2524 citations
Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease.
2014-10-2088 citations
Cytopenia and leukocyte recovery shape cytokine fluctuations after myeloablative allogeneic hematopoietic stem cell transplantation.
2011-12-0133 citations